Search Results - "Lebas, Françoise Borsa"

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study by Piroth, Lionel, Pol, Stanislas, Miailhes, Patrick, Lacombe, Karine, Lopes, Amanda, Fillion, Aurélie, Loustaud-Ratti, Véronique, Borsa-Lebas, Françoise, Salmon, Dominique, Rosenthal, Eric, Carrat, Fabrice, Cacoub, Patrice

“…Background & Aims To compare the management of chronic hepatitis B (CHB) and its evolution over time in currently followed HIV‐positive and HIV‐negative…”
Get full text

Urolithiasis in HIV-Positive Patients Treated with Atazanavir by Couzigou, Carine, Daudon, Michel, Meynard, Jean Luc, Lebas, Françoise Borsa, Higueret, Denise, Escaut, Lélia, Zucman, David, Liotier, Jean-Yves, Quencez, Jean-Louis, Asselah, Karine, May, Thierry, Neau, Didier, Vittecoq, Daniel

“…Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis…”
Get full text

Successful Treatment of Metronidazole- and Albendazole-Resistant Giardiasis with Nitazoxanide in a Patient with Acquired Immunodeficiency Syndrome by Abboud, Philippe, Lemée, Véronique, Gargala, Gilles, Brasseur, Philippe, Ballet, Jean Jacques, Borsa-Lebas, Françoise, Caron, François, Favennec, Loïc

“…A case of metronidazole- and albendazole-resistant giardiasis in a patient with the acquired immunodeficiency syndrome was successfully treated with…”
Get full text

Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study by Hocqueloux, Laurent, Choisy, Philippe, Le Moal, Gwenaël, Borsa-Lebas, Françoise, Plainchamp, David, Legac, Eric, Prazuck, Thierry, de la Tribonnière, Xavier, Yazdanpanah, Yazdan, Parienti, Jean-Jacques

“…Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy…”
Get full text

Complicated Atazanavir-Associated Cholelithiasis: A Report of 14 Cases by Rakotondravelo, Soloniaina, Poinsignon, Yves, Borsa-Lebas, Françoise, de la Blanchardière, Arnaud, Michau, Christophe, Jantzem, Hélène, Massy, Nathalie, Polard, Elisabeth, Giroux, Fanny, Kerspern, Hélène, Meskar, Ahmed, Hue, Guy, Tribut, Olivier, Arvieux, Cédric, Tattevin, Pierre

“…Fourteen human immunodeficiency virus (HIV)-infected patients receiving an atazanavir (ATV)-based antiretroviral regimen developed complicated cholelithiasis…”
Get full text

Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy by Leporrier, Jeremie, Etienne, Manuel, Chapuzet, Claire, Peytavin, Gilles, Bord, Stephane, Borsa-Lebas, Françoise, Caron, François, Plantier, Jean-Christophe, Mourez, Thomas

“…Highlights • We design a novel well-tolerated and effective rescue treatment against HIV-1. • We observe the tolerance of an unusual association of rilpivirine…”
Get full text

HIV-1 resistance genotyping on dried serum spots by PLANTIER, Jean-Christophe, DACHRAOUI, Raoudha, LEMEE, Véronique, GUEUDIN, Marie, BORSA-LEBAS, Francoise, CARON, Francois, SIMON, Francois

“…To assess the feasibility of HIV-1 group M resistance genotyping on dried serum spots, by testing samples from previously untreated patients, patients on…”
Get full text

Influence of rifampin on the pharmacokinetics of pefloxacin by Humbert, G, Brumpt, I, Montay, G, Le Liboux, A, Frydman, A, Borsa-Lebas, F, Moore, N

“…Pefloxacin and rifampin are frequently associated in the antibiotic therapy of deep-seated, and especially bone-located, infections. The influence of rifampin,…”
Get more information

Similarity of Expression of Activation Markers and CD28 on γδ and αβ-Receptor T Cells in HIV Infection by Jouen-Beades, Fabienne, Gilbert, Danièle, Ramzaoui, Soumia, Borsa-Lebas, Françoise, Humbert, Guy, Tron, François

“…During human immunodeficiency virus (HIV) infection, phenotypic analysis of circulating γδ+T cells showed a downregulation of the CD28 surface antigen, as…”
Get full text

During HIV Infection, CD4 + CD38 + T-cells are the predominant circulating CD4 + subset whose HLA-DR positivity increases with disease progression and whose Vβ repertoire is similar to that of CD4 + CD38 − T-cells by Ramzaoui, Soumia, Jouen-Beades, Fabienne, Gilbert, Danièle, Borsa-Lebas, Françoise, Michel, Yvon, Humbert, Guy, Tron, François

“…Three-color automated flow cytometry was carried out on peripheral blood CD4 + and CD8 + T-lymphocytes of 42 HIV-positive patients using tri-color anti-CD4 or…”
Get full text